期刊文献+

p27在慢性粒细胞白血病中表达的研究 被引量:3

THE STUDY OF THEEXPRESSI ON OF p27 IN CML
原文传递
导出
摘要 目的:研究细胞周期蛋白依赖激酶抑制物p27在慢性粒细胞白血病(CML)患者中的表达,探讨p27在CML中的作用机制及其临床意义。方法:应用蛋白印迹(Western蛳blot)(DAB显色与化学发光显示)法检测27例CML患者及10例对照组p27的表达,分析p27在CML中有无异常表达及其表达与病情进展和预后的关系。结果:27例CML患者化学发光法显示p27阳性表达率(37.04 %)明显低于对照组(80.00 %)(P<0.05)。在27例CML患者中,p27阳性表达率在高危、中危、低危3组中分别为0、28.57 %、44.44 %;高危组与低危组间有明显差异(P<0.05),而高危组与中危组、中危组与低危组间无差异。化学发光法结果优于DAB显色法。结论:p27在CML中有异常低表达,提示p27在CML中有抑癌基因的作用,其表达水平可能与CML患者的病情进展及预后相关。 Objective:Thepurposeistostudytheexpressionofp27inpatientswithchroicmyelogenousleukemia(CML),andevaluatethefunctionandclinicalvalueofp27inchronicleukemia.Methods:Theexpres-sionofp27wasmeasuredinthebonemarrowsamplesof27patientswithCMLand10casesincontrolgroupwereexaminedbywestern蛳blotmethod(DABmethodandchemicalphotoflurography).Andanalysetherelationshipbetweentheexpressionlevelofp27andtheprogressionandprognosisofpatientswithCML.Results:Thepositiverateofp27in27CMLpatientswere37.04%,whichwasapparentlylowerthanthecontrolgroupwithrateof80%,therewassignificantdifferencebetweenpatientswithCMLandcontrolgroup(P<0.05),andthepositiveexpressionofp27inhighriskgroup(0)waslowerthanthatinlowriskgroup(38.8%)ofCMLpatients,thedifferencebetweenthemwasapparent(P <0.05).theresultbychemicalphotoflurographyisbetterthanonebyDABmethod.Conclusion:p27hadlowexpressioninleukemiapa-tients,Ourresultssuggestpotentialrolesofp27inleukemiamightbeananti蛳oncogene,andtheexpressionlevelofp27isprobablycorrelatedwiththeprogressionandprognosisofpatientswithCML.
出处 《白血病.淋巴瘤》 CAS 2004年第3期156-158,共3页 Journal of Leukemia & Lymphoma
关键词 慢性粒细胞白血病 蛋白印迹 化学发光法 p27 CML Western蛳blot Chemicalphotoflurography
  • 相关文献

参考文献10

  • 1Vidal A, Millard S S, Miller J P, et al. Rho activity can alter the translation of p27 mRNA and is important for Rasv12 - induced transformation in a manner dependent on p27 status[J]. Biol Chem,2002, 19(27):16433-16440. 被引量:1
  • 2Barata J T, Cardoso A A, Nadler L M, et al. lnterleukin-7 promotes survival and cell cyclin progression of T cell acute lymphoblastic leukemia cells by down- regulating the cyclin dependent kinase inhibitor p27[J]. Blood, 2001,98(5): 1524-1531. 被引量:1
  • 3Shiohara M, Uskokovic M, Hisatake J, et al. 24 - oxo metabolites of vitamin D3 analogues:disassociation of their prominent antileukemic effects from their lack of calcium modulation[J]. Cancer Res, 2001,67(8):3361-3368. 被引量:1
  • 4Quentmeier H, Zaborski M, Drexler H G. Effects of thrombopoitin interleukin- 3 and the kinase inhibitor K- 252a on growth and polyploidization of the megakarycoytie cell line M-07e [J].Leukemia, 1998, 12(10):1603-1611. 被引量:1
  • 5Jiang Y, Zhao R C, Verfaillie C M, Abnormal integrin- mediated regulation of chronic myelogenous leukemia CD+34 cell proliferation:bcr/abl up-regulates the cyclindependent kinase inhibitor, p27,which is relocated to the cell cytoplasm and incapable of reg 被引量:1
  • 6Shiotsu Y, Neckers L M, Wortman I, et al. Nove oxime derivatives of rakicicol induce erythroid differentiation associated with preferential G(1) phase accumulation against chronic myelogenous leukemia cells through destabilization of bcr - abl with HSP90c 被引量:1
  • 7Takeno S, Noguchi T, Kikuchi R, et al. Proguostic value of cyclinB1 in patients with esophageal squamous cell carcinoma [J]. Am Cancer, 2002,94:2874-2781. 被引量:1
  • 8Radosevic N, Delmer A, Tang R, et al. Cell cyclin regulatory protein expression in fresh acute myeloid leukemia cells and after drug exposure[J]. Leukemia, 2001, 15(4):559-566. 被引量:1
  • 9Jung C W, Kin E S, Seol J G, et al. Antiprolfferatiive effcet of a vitamin D3 analog, EB1089, on HL-60 cells by the induction of TGF-beta receptor[J]. LeukRes, 1999,23(12):1105-1112. 被引量:1
  • 10Jonuleit T, Van der Kuip H, Miething C, et al. Bcr/abl kinase downregulation cyclin-dependent kinase inhibitor p27 in human and murine cell liines[J]. Blood, 2000, 96(5):1933-1939. 被引量:1

同被引文献35

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部